Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000237

Chief Financial Officer sold 24,079 shares at an average $271.59 ($6,539,634)

  • Chief Financial Officer acquired 24,079 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hippel James Chief Financial Officer 2020-07-06 Option exercise +21,502 $108.49 $2,332,752 30,809 D: show line 1 in the form
Hippel James Chief Financial Officer 2020-07-06 Sale −9,571 $270.45 $2,588,508 21,238 D: show line 2 in the form
Hippel James Chief Financial Officer 2020-07-06 Sale −3,781 $271.53 $1,026,667 17,457 D: show line 3 in the form
Hippel James Chief Financial Officer 2020-07-06 Sale −4,947 $272.34 $1,347,256 12,510 D: show line 4 in the form
Hippel James Chief Financial Officer 2020-07-06 Sale −1,934 $273.71 $529,358 10,576 D: show line 5 in the form
Hippel James Chief Financial Officer 2020-07-06 Sale −1,269 $274.52 $348,363 9,307 D: show line 6 in the form
Hippel James Chief Financial Officer 2020-07-07 Option exercise +2,577 $108.49 $279,579 11,884 D: show line 7 in the form
Hippel James Chief Financial Officer 2020-07-07 Sale −414 $270.56 $112,010 11,470 D: show line 8 in the form
Hippel James Chief Financial Officer 2020-07-07 Sale −1,663 $271.40 $451,341 9,807 D: show line 9 in the form
Hippel James Chief Financial Officer 2020-07-07 Sale −500 $272.26 $136,130 9,307 D: show line 10 in the form
Open-market sales · 24,079 sh · avg $271.59 · $6,539,634

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hippel James Chief Financial Officer 2020-07-06 Option exercise · Stock Options (Right to Buy) −21,502 18,486 D: show line 11 in the form
Hippel James Chief Financial Officer 2020-07-07 Option exercise · Stock Options (Right to Buy) −2,577 15,909 D: show line 12 in the form
Loading xslF345X03/edgar.xml…